BiotechTube
INCELL

INCELL

San Antonio, United States· Est.
incell.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $11M

Overview

INCELL operates as a hybrid products manufacturer and contract development and manufacturing organization (CDMO) in the regenerative medicine space. The company leverages its GMP capabilities to support both its own therapeutic programs and external clients, with a focus on cell culture media, transport solutions, and proprietary cell lines. Through a strategic alliance with 4RMED LLC, INCELL manages clinical development for programs targeting conditions like ALS, pneumonia, and pediatric necrotizing enterocolitis. Its business model integrates product sales, contract services, and internal therapeutic development.

Neurology (ALS)Infectious DiseaseGastroenterologyOncology

Technology Platform

Proprietary cell culture media (M3™, M4™ families), cryopreservation media, cell processing and transport solutions (ZSol-F™, ZTM™), and GMP cell/tissue manufacturing and storage services.

Funding History

2
Total raised:$11M
Series A$8M
Seed$3M

Opportunities

The booming cell and gene therapy CDMO market provides a major growth opportunity for its contract services.
Success in its internal clinical pipeline, particularly in high-need areas like ALS and anti-microbial resistance, could deliver transformative value.
Its personalized cancer cell banking service aligns with the growing precision medicine trend.

Risk Factors

Clinical failure of its lead ALS or other therapeutic programs poses a significant development and reputational risk.
The company faces intense competition from larger, well-funded CDMOs and life science reagent suppliers.
Maintaining GMP compliance and managing resource allocation between client services and internal R&D are ongoing operational challenges.

Competitive Landscape

INCELL competes with large, public CDMOs (e.g., Lonza, Catalent) in cell therapy manufacturing and with life science tools companies (e.g., Thermo Fisher) in media and reagents. Its internal pipeline places it against other biotechs in neurology and infectious disease. Its niche is its long-standing expertise, integrated service-product model, and focus on specific regenerative medicine applications.

More companies in Biologics / Biosimilars →More companies in United States →